Musk Proposes to Proceed With Twitter Deal
Bloomberg Businessweek
00:00
Is There a Conversation About Keeping These Things Separated?
Pfizer isn't the only one I actually spoke with the chief scientific officer of Eli Lilly and they said you know with something like messenger RNA it's a technology. You should expect every pharmaceutical company to use that same technology as one of the fundamental pillars of building out a drug business moving forward. But say these things stay separate even like what is that what does that business look like are they is there a conversation about keeping these things separate and maybe that's more lucrative than if they're one.
Play episode from 19:29
Transcript
